Revenue
2022
2023
2024
2025
Immupharma plc (IMM)
Price—Loading quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2024
2025
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 | — |
| Research & development | £1.3M | £1.2M | £2.0M | £2.0M | — |
| Operating expenses | £2.5M | £2.3M | £3.1M | £3.0M | — |
| Operating income | −£2.5M | −£2.3M | −£3.1M | −£3.0M | — |
| Net income | −£1.8M | −£2.5M | −£2.9M | −£3.8M | — |
| Basic EPSper basic share | — | -£0.01 | -£0.01 | -£0.01 | -£0.03 |
| Diluted EPSper diluted share | — | -£0.01 | -£0.01 | -£0.01 | -£0.03 |